N Hayashi Selected Research

N Hayashi Research Topics

Disease

25	Neoplasms (Cancer) 01/2023 - 02/2000
18	Chronic Hepatitis C 03/2015 - 07/2000
13	Hepatocellular Carcinoma (Hepatoma) 01/2016 - 02/2000
8	Infections 05/2014 - 01/2000
7	Neoplasm Metastasis (Metastasis) 03/2016 - 01/2000
6	Hepatitis 12/2009 - 07/2000
4	Prostatic Neoplasms (Prostate Cancer) 09/2014 - 02/2000
4	Hepatitis C 05/2014 - 01/2000
4	Type 2 Diabetes Mellitus (MODY) 10/2013 - 04/2012
4	Fibrosis (Cirrhosis) 12/2012 - 03/2001
4	Hydrocephalus (Hydrocephaly) 04/2009 - 10/2000
4	Pancreatitis 10/2008 - 08/2000
4	Cysts 08/2005 - 03/2000
4	Hypothermia 01/2003 - 03/2000
3	Necrosis 10/2008 - 03/2000
3	Inflammation (Inflammations) 10/2008 - 08/2000
3	Carcinoma (Carcinomatosis) 10/2001 - 01/2000
3	Stomach Neoplasms (Stomach Cancer) 06/2001 - 01/2000
2	Breast Neoplasms (Breast Cancer) 03/2016 - 02/2001
2	Diabetes Mellitus 12/2012 - 11/2000
2	AIDS-Related Complex (ARC) 06/2012 - 03/2001
2	Hyperplasia 11/2006 - 01/2004
2	Abscess 08/2004 - 07/2000
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2003 - 01/2003
2	Insulinoma 12/2002 - 06/2000
2	Hepatitis B 09/2001 - 08/2001
2	Acute Liver Failure (Fulminant Hepatic Failure) 09/2001 - 08/2000
2	Coma (Comas) 07/2001 - 06/2000
2	Macular Degeneration (Age-Related Maculopathy) 04/2001 - 09/2000
2	Chronic Hepatitis (Chronic Active Hepatitis) 11/2000 - 07/2000
2	Liver Diseases (Liver Disease) 09/2000 - 08/2000
2	Massive Hepatic Necrosis 08/2000 - 07/2000
2	Brain Hypoxia (Cerebral Hypoxia) 03/2000 - 03/2000
2	Brain Edema (Cerebral Edema) 03/2000 - 03/2000
2	Adenocarcinoma 01/2000 - 01/2000
1	Hyperostosis 04/2020
1	Hypocalcemia 01/2019
1	Osteoporosis 01/2019
1	Renal Insufficiency (Renal Failure) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Frailty 01/2017
1	Pathologic Complete Response 03/2016

Drug/Important Bio-Agent (IBA)

14	InterferonsIBA 03/2015 - 07/2000
6	Ribavirin (Virazole)FDA LinkGeneric 03/2015 - 06/2007
6	AntigensIBA 08/2011 - 07/2000
5	Proteins (Proteins, Gene)FDA Link 11/2012 - 01/2000
4	InterleukinsIBA 05/2012 - 08/2000
4	Interferon-alpha (Interferon Alfa)IBA 06/2007 - 09/2000
3	Indicators and Reagents (Reagents)IBA 01/2017 - 06/2001
3	Antiviral Agents (Antivirals)IBA 03/2015 - 05/2001
3	Glucose (Dextrose)FDA LinkGeneric 10/2013 - 12/2012
3	Therapeutic UsesIBA 02/2012 - 10/2001
3	Complementary DNA (cDNA)IBA 06/2003 - 04/2000
3	EnzymesIBA 12/2002 - 02/2000
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2002 - 02/2000
3	Fas Ligand Protein (Fas Ligand)IBA 10/2001 - 08/2000
3	Messenger RNA (mRNA)IBA 02/2001 - 01/2000
3	CytokinesIBA 10/2000 - 03/2000
2	telaprevirIBA 03/2015 - 02/2012
2	Alanine Transaminase (SGPT)IBA 05/2014 - 12/2009
2	LinagliptinIBA 04/2013 - 04/2012
2	voglibose (Basen)IBA 04/2013 - 04/2012
2	Dopamine (Intropin)FDA LinkGeneric 11/2009 - 03/2000
2	Tyrosine (L-Tyrosine)FDA Link 11/2009 - 01/2001
2	RNA (Ribonucleic Acid)IBA 08/2009 - 07/2000
2	CeruletideIBA 10/2008 - 08/2000
2	Interleukin-12 (IL 12)IBA 06/2007 - 10/2001
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2007 - 02/2000
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 01/2003 - 03/2000
2	AutoantibodiesIBA 01/2003 - 03/2001
2	acarboxyprothrombin (PIVKA)IBA 11/2001 - 02/2000
2	fas Receptor (CD95 Antigen)IBA 09/2001 - 08/2000
2	Interferon-gamma (Interferon, gamma)IBA 05/2001 - 11/2000
2	AntibodiesIBA 03/2001 - 01/2000
2	Carcinoembryonic AntigenIBA 02/2001 - 10/2000
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2000 - 08/2000
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2000 - 08/2000
2	Immunoglobulin G (IgG)IBA 07/2000 - 01/2000
2	Immunoglobulin M (IgM)IBA 07/2000 - 01/2000
1	human ERBB2 proteinIBA 01/2023
1	MineralsIBA 04/2020
1	Denosumab FDA Link 01/2019
1	Bone Density Conservation AgentsIBA 01/2019
1	CalciumIBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 03/2016
1	Phenobarbital (Luminal)FDA Link 03/2016
1	Hormones (Hormone)IBA 03/2016

Therapy/Procedure

22	Therapeutics 03/2015 - 07/2000
4	Radiotherapy 03/2015 - 01/2001
3	Liver Transplantation 09/2001 - 07/2001
3	Transplantation 09/2001 - 09/2000
2	Neoadjuvant Therapy 03/2016 - 03/2002
2	Drug Therapy (Chemotherapy) 03/2015 - 01/2001
2	Prostatectomy (Retropubic Prostatectomy) 09/2014 - 01/2007
2	Ventriculoperitoneal Shunt 04/2009 - 12/2000
2	Craniotomy 10/2004 - 08/2004
2	Artificial Liver (Bioartificial Liver) 09/2001 - 12/2000
2	Lymph Node Excision (Lymph Node Dissection) 06/2001 - 01/2000
2	Gastrectomy 06/2001 - 01/2000
2	Intraperitoneal Injections 11/2000 - 08/2000